Detalles de la búsqueda
1.
A Fermented Wheat Germ Extract Contains Protein Components Active against NSCLC Xenografts In Vivo.
Curr Issues Mol Biol
; 45(9): 7087-7096, 2023 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37754232
2.
The HB22.7-vcMMAE antibody-drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity.
Cancer Immunol Immunother
; 65(10): 1169-75, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27506529
3.
Efficacy of Combined Histone Deacetylase and Checkpoint Kinase Inhibition in a Preclinical Model of Human Burkitt Lymphoma.
Mol Med
; 21(1): 824-832, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26322845
4.
Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma.
Br J Haematol
; 165(3): 375-81, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24606326
5.
A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia.
Am J Hematol
; 94(11): E291-E294, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31379016
6.
Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphoma.
Mol Pharm
; 9(6): 1727-35, 2012 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22530955
7.
The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies alone.
Cancer Immunol Immunother
; 60(6): 771-80, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21347809
8.
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD).
Invest New Drugs
; 28(3): 260-7, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19306119
9.
Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenografts.
Cancer Immunol Immunother
; 58(12): 2051-8, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19437017
10.
Treatment of non-Hodgkin's lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy.
Cancer Immunol Immunother
; 58(10): 1715-22, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19294384
11.
Imaging and pharmacokinetics of (64)Cu-DOTA-HB22.7 administered by intravenous, intraperitoneal, or subcutaneous injection to mice bearing non-Hodgkin's lymphoma xenografts.
Mol Imaging Biol
; 11(2): 79-87, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-18949521
12.
A purified, fermented, extract of Triticum aestivum has lymphomacidal activity mediated via natural killer cell activation.
PLoS One
; 13(1): e0190860, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29304125
13.
Effect of antilymphoma antibody, 131I-Lym-1, on peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.
Cancer Biother Radiopharm
; 22(4): 521-30, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17803447
14.
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody.
Clin Cancer Res
; 11(16): 5920-7, 2005 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16115934
15.
Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry.
J Nucl Med
; 46(6): 1034-41, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15937317
16.
Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice.
Clin Cancer Res
; 9(10 Pt 2): 3854S-64S, 2003 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14506183
17.
Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT.
Clin Cancer Res
; 9(10 Pt 2): 3938S-44S, 2003 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14506192
18.
Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibody.
Cancer Biother Radiopharm
; 20(6): 662-70, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16398618
19.
Histone deacetylase inhibition enhances the lymphomacidal activity of the anti-CD22 monoclonal antibody HB22.7.
Leuk Res
; 38(11): 1320-6, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25241275
20.
Targeting CD22 in B-cell malignancies: current status and clinical outlook.
BioDrugs
; 27(4): 293-304, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23696252